Literature DB >> 31266369

Performance of the Meta-Analysis Global Group in Chronic Heart Failure Score in Black Patients Compared With Whites.

Ryhm Radjef1, Edward L Peterson2, Alexander Michaels1, Bin Liu2, Hongsheng Gui3, Hani N Sabbah1, John A Spertus4, L Keoki Williams3, David E Lanfear1,3.   

Abstract

BACKGROUND: Risk stratification is critical in heart failure (HF) and the Meta-Analysis Global Group in Chronic HF (MAGGIC) score is a validated tool derived from ~40,000 patients. However, few of these patients self-identified as black, raising uncertainty regarding performance in blacks with HF. METHODS AND
RESULTS: This study analyzed a racially diverse group of 4046 patients (1646 black and 2400 white) from a single center from 2007 to 2015. Baseline characteristics were collected to tabulate MAGGIC score and test its discrimination and calibration within race groups. The primary end point was all-cause mortality. Death was detected using system records and the social security death master file. Discrimination was tested using Cox models of MAGGIC score stratified by race, and combined analysis including MAGGIC, race, and MAGGIC×race. Calibration was assessed using linear regression models and plots of observed versus predicted data. Overall, 901 (21%) patients died during 1-year follow-up. MAGGIC score discrimination was similar in both race groups in terms of C statistic (0.707±0.027 versus 0.725±0.014, for black versus white; P=0.556) and the hazard ratio (HR) per MAGGIC point was 1.12 in black patients (95% CI, 1.10-1.14) and 1.13 in white patients (95% CI, 1.12-1.14). Race was a significant correlate of survival, with better survival in black patients compared with white (HR, 0.66; 95% CI, 0.56-0.78), but the interaction of MAGGIC×race was not significant (β=-0.013; P=0.16), and adding race to the model did not improve discrimination (C statistic for MAGGIC versus MAGGIC+race, 0.721 versus 0.722; P=0.79). In calibration testing, the slope was not significantly different from 1 in either group, but the groups differed from each other, and it was closer to unity among black patients (0.94 versus 1.4; P=0.004).
CONCLUSIONS: These data support the use of the MAGGIC score to risk stratify black patients with HF.

Entities:  

Keywords:  heart failure; linear models race; risk

Mesh:

Year:  2019        PMID: 31266369      PMCID: PMC6613810          DOI: 10.1161/CIRCOUTCOMES.118.004714

Source DB:  PubMed          Journal:  Circ Cardiovasc Qual Outcomes        ISSN: 1941-7713


  26 in total

Review 1.  Heart failure in African Americans: a cardiovascular engima.

Authors:  C W Yancy
Journal:  J Card Fail       Date:  2000-09       Impact factor: 5.712

2.  Gender and risk of adverse outcomes in heart failure.

Authors:  Wendy Y Lee; Angela M Capra; Nancy G Jensvold; Jerry H Gurwitz; Alan S Go
Journal:  Am J Cardiol       Date:  2004-11-01       Impact factor: 2.778

3.  Differences in the incidence of congestive heart failure by ethnicity: the multi-ethnic study of atherosclerosis.

Authors:  Hossein Bahrami; Richard Kronmal; David A Bluemke; Jean Olson; Steven Shea; Kiang Liu; Gregory L Burke; João A C Lima
Journal:  Arch Intern Med       Date:  2008-10-27

4.  Assessing the performance of prediction models: a framework for traditional and novel measures.

Authors:  Ewout W Steyerberg; Andrew J Vickers; Nancy R Cook; Thomas Gerds; Mithat Gonen; Nancy Obuchowski; Michael J Pencina; Michael W Kattan
Journal:  Epidemiology       Date:  2010-01       Impact factor: 4.822

5.  The Seattle Heart Failure Model: prediction of survival in heart failure.

Authors:  Wayne C Levy; Dariush Mozaffarian; David T Linker; Santosh C Sutradhar; Stefan D Anker; Anne B Cropp; Inder Anand; Aldo Maggioni; Paul Burton; Mark D Sullivan; Bertram Pitt; Philip A Poole-Wilson; Douglas L Mann; Milton Packer
Journal:  Circulation       Date:  2006-03-13       Impact factor: 29.690

6.  Heart failure incidence and survival (from the Atherosclerosis Risk in Communities study).

Authors:  Laura R Loehr; Wayne D Rosamond; Patricia P Chang; Aaron R Folsom; Lloyd E Chambless
Journal:  Am J Cardiol       Date:  2008-02-14       Impact factor: 2.778

7.  Race, quality of care, and outcomes of elderly patients hospitalized with heart failure.

Authors:  Saif S Rathore; JoAnne M Foody; Yongfei Wang; Grace L Smith; Jeph Herrin; Frederick A Masoudi; Pamela Wolfe; Edward P Havranek; Diana L Ordin; Harlan M Krumholz
Journal:  JAMA       Date:  2003-05-21       Impact factor: 56.272

8.  Are there race/ethnicity differences in outpatient congestive heart failure management, hospital use, and mortality among an insured population?

Authors:  Jennifer Elston Lafata; Manel Pladevall; George Divine; Melissa Ayoub; Edward F Philbin
Journal:  Med Care       Date:  2004-07       Impact factor: 2.983

9.  Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model.

Authors:  Douglas S Lee; Peter C Austin; Jean L Rouleau; Peter P Liu; David Naimark; Jack V Tu
Journal:  JAMA       Date:  2003-11-19       Impact factor: 56.272

10.  Utility of the Seattle Heart Failure Model in patients with advanced heart failure.

Authors:  Andreas P Kalogeropoulos; Vasiliki V Georgiopoulou; Grigorios Giamouzis; Andrew L Smith; Syed A Agha; Sana Waheed; Sonjoy Laskar; John Puskas; Sandra Dunbar; David Vega; Wayne C Levy; Javed Butler
Journal:  J Am Coll Cardiol       Date:  2009-01-27       Impact factor: 24.094

View more
  2 in total

1.  Suppression tumorigenicity 2 (ST2) turbidimetric immunoassay compared to enzyme-linked immunosorbent assay in predicting survival in heart failure patients with reduced ejection fraction.

Authors:  Lindsey Aurora; Edward Peterson; Hongsheng Gui; Nicole Zeld; James McCord; Yigal Pinto; Bernard Cook; Hani N Sabbah; L Keoki Williams; James Snider; David E Lanfear
Journal:  Clin Chim Acta       Date:  2020-09-12       Impact factor: 3.786

2.  Plasma Proteomic Profile Predicts Survival in Heart Failure With Reduced Ejection Fraction.

Authors:  Hongsheng Gui; Ruicong She; Jasmine Luzum; Jia Li; Timothy D Bryson; Yigal Pinto; Hani N Sabbah; L Keoki Williams; David E Lanfear
Journal:  Circ Genom Precis Med       Date:  2021-05-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.